TABLE 1.
porA genosubtypes of N. meningitidis
| No. of isolates | Genosubtypea
|
Sourceb | No. in serogroup:
|
|||
|---|---|---|---|---|---|---|
| VR1 | VR2 | VR3 | B | C | ||
| 2 | 7 | 16 | 35 | CSF | 2 | 0 |
| 1 | 5a | 1 | 35-1 | Nasoph | 1 | |
| 10 | 7-1 | 1 | 35-1 | CSF | 10 | 0 |
| 2 | 7-2 | 1 | 35-1 | CSF | 2 | 0 |
| 1 | 7-2 | 13-1 | 35-1 | CSF | 0 | 1 |
| 1 | 7-4 | 1 | 35-1 | CSF | 1 | 0 |
| 15 | 12-5a | 1 | 35-1 | Nasoph | 15 | 0 |
| 1 | 20 | 9 | 35-1 | CSF | 1 | 0 |
| 1 | 22 | 14-6 | 35-1 | CSF | 0 | 1 |
| 1 | 5 | 2 | 36 | CSF | 1 | 0 |
| 1 | 7-4 | 1 | 36 | CSF | 1 | 0 |
| 1 | 12-5a | 15a | 36 | Nasoph | 1 | 0 |
| 2 | 12-5a | 15 | 36 | Nasoph | 2 | 0 |
| 35 | 19 | 15 | 36 | CSF | 35 | 0 |
| 1 | 22 | 14-6 | 36 | CSF | 1 | 0 |
| 1 | 22 | 14 | 36 | CSF | 1 | 0 |
| 3 | 5 | 2 | 36-2 | CSF | 0 | 3 |
| 2 | 5-1 | 10-1 | 36-2 | CSF | 1 | 1 |
| 1 | 5-1 | 2-2 | 36-2 | CSF | 1 | 0 |
| 1 | 5-1 | 10-8 | 36-2 | CSF | 1 | 0 |
| 4 | 22 | 14-6 | 36-2 | CSF | 0 | 4 |
| 1 | 19 | 15 | 36-2 | CSF | 0 | 1 |
| 1 | 19 | 15 | 37 | CSF | 1 | 0 |
| 2 | 5-2 | 10 | 37-1 | CSF | 0 | 2 |
| 2 | 21 | 16 | 37-1 | CSF | 2 | 0 |
| 1 | 7-2 | 3 | 38 | CSF | 1 | 0 |
| 1 | 18 | 14 | 38 | CSF | 1 | 0 |
| 2 | 18-1 | 3 | 38 | CSF | 0 | 2 |
| 1 | 7a | 25-3 | 38-1 | Nasoph | 1 | 0 |
| 1 | 12-5a | 25 | 38-1 | Nasoph | 1 | 0 |
| 1 | 12-5a | 25-3 | 38-1 | Nasoph | 1 | 0 |
| 1 | 12-5a | 4a | 38-1 | Nasoph | 1 | 0 |
a
An “a” at the end of a genosubtype designation denotes a new variant with more than 50% similarity to the indicated variant.
b
CSF, cerebrospinal fluid; Nasoph, nasopharyngeal sample.